Who makes • harpagozid • boswellin = LOXACON?

• harpagozid • boswellin = LOXACON is developed by Polyclinic of the Hospitaller Brothers of St. John of God, Budapest.

What development phase is • harpagozid • boswellin = LOXACON in?

• harpagozid • boswellin = LOXACON is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

• harpagozid • boswellin = LOXACON

Polyclinic of the Hospitaller Brothers of St. John of God, Budapest · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	• harpagozid • boswellin = LOXACON
Also known as	Physiotherapy(exercise)
Sponsor	Polyclinic of the Hospitaller Brothers of St. John of God, Budapest
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Clinical Efficacy and Safety of Loxacon Dietary Supplement Capsules at Patients With Knee Arthrosis (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• harpagozid • boswellin = LOXACON CI brief — competitive landscape report
• harpagozid • boswellin = LOXACON updates RSS · CI watch RSS
Polyclinic of the Hospitaller Brothers of St. John of God, Budapest portfolio CI